Study Leaves Transvaginal Mesh Controversy at Impasse

(MedPage Today) -- Transvaginal mesh proved noninferior to native tissue repair for vaginal prolapse but missed the superiority target in an FDA-mandated, postmarket, prospective parallel-cohort study.
The 36-month composite treatment success...